Altimmune Inc (ALT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Sales | 10,641 | 10,190 | 17,913 | 25,176 | 24,266 |
| Gross Profit | 10,641 | 10,190 | 17,913 | 25,176 | 24,266 |
| Operating Expenses | 14,044 | 20,382 | 28,752 | 31,442 | 35,992 |
| Operating Income | -3,403 | -10,191 | -10,839 | -6,266 | -11,726 |
| Interest Expense | 0 | 0 | 367 | 325 | 55 |
| Other Income | 24 | 298 | -451 | 1,867 | 7,983 |
| Pre-tax Income | -3,379 | -9,894 | -11,657 | -4,725 | -3,798 |
| Income Tax | 62 | 62 | 62 | 196 | N/A |
| Net Income Continuous | -3,441 | -9,955 | -11,718 | -4,920 | -3,798 |
| Net Income | $-3,441 | $-9,955 | $-11,718 | $-4,920 | $-3,798 |
| EPS Basic Total Ops | -15.02 | -51.05 | -69.07 | -30.03 | -24.02 |
| EPS Basic Continuous Ops | -16.15 | -51.96 | -69.46 | -30.58 | -24.09 |
| EPS Diluted Total Ops | -15.02 | -51.05 | -69.07 | -30.03 | -24.02 |
| EPS Diluted Continuous Ops | -16.15 | -51.96 | -69.46 | -30.58 | -24.09 |
| EBITDA(a) | $-3,261 | $-10,041 | $-10,657 | $-5,963 | $-11,265 |